Author:
Ngamphaiboon Nuttapong,Dy Grace K.,Ma Wen Wee,Zhao Yujie,Reungwetwattana Thanyanan,DePaolo Dawn,Ding Yi,Brady William,Fetterly Gerald,Adjei Alex A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference29 articles.
1. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358(11):1148–1159. doi: 10.1056/NEJMra072067
2. Feinberg AP (2008) Epigenetics at the epicenter of modern medicine. JAMA : the j of the Am Med Assoc 299(11):1345–1350. doi: 10.1001/jama.299.11.1345
3. Xu WS, Parmigiani RB, Marks PA (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26(37):5541–5552. doi: 10.1038/sj.onc.1210620
4. Burgess AJ, Pavey S, Warrener R, Hunter LJ, Piva TJ, Musgrove EA, Saunders N, Parsons PG, Gabrielli BG (2001) Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol 60(4):828–837
5. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4):391–400. doi: 10.1038/ng1531
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献